Market Research Logo

DURECT Corporation (DRRX) - Financial and Strategic SWOT Analysis Review

DURECT Corporation (DRRX) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

DURECT Corporation (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s major products include Alzet, an osmotic pump; and Lactel, a biodegradable polymer. The company’s product pipeline comprises DUR-928 indicated for treatment of acute organ injuries and metabolic/lipid disorders; Remoxy, indicated for chronic pain; Posimir, indicated for post-operative pain; Eladur, indicated for post herpetic neuralgia; Oradur, indicated for chronic pain and attention deficit hyperactivity disorder; and Relday, indicated for Schizophrenia and bipolar disorder. Durect’s major drug delivery technology platforms include Saber, Cloud, Oradur and Transdur. The company operates in the US, Europe, Japan and other countries. Durect is headquartered in California, the US.

DURECT Corporation Key Recent Developments

Oct 31, 2016: DURECT Announces Third Quarter 2016 Financial Results and Update of Programs
Aug 01, 2016: DURECT Announces Second Quarter 2016 Financial Results and Update of Programs
May 05, 2016: DURECT Announces First Quarter 2016 Financial Results and Update of Programs
Feb 29, 2016: DURECT Announces Fourth Quarter 2015 Financial Results and Update of Programs
Nov 02, 2015: DURECT Announces Third Quarter 2015 Financial Results and Update of Programs

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
DURECT Corporation - Key Facts
DURECT Corporation - Key Employees
DURECT Corporation - Key Employee Biographies
DURECT Corporation - Major Products and Services
DURECT Corporation - Medical Equipment Pipeline Products Data
DURECT Corporation Pipeline Products by Equipment Type
DURECT Corporation Pipeline Products by Development Stage
DURECT Corporation - History
DURECT Corporation - Company Statement
DURECT Corporation - Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
DURECT Corporation - Business Description
DURECT Corporation - Corporate Strategy
DURECT Corporation - SWOT Analysis
SWOT Analysis - Overview
DURECT Corporation - Strengths
DURECT Corporation - Weaknesses
DURECT Corporation - Opportunities
DURECT Corporation - Threats
DURECT Corporation - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
DURECT Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
DURECT Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
DURECT Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
DURECT Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
DURECT Corporation, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 31, 2016: DURECT Announces Third Quarter 2016 Financial Results and Update of Programs
Aug 01, 2016: DURECT Announces Second Quarter 2016 Financial Results and Update of Programs
May 05, 2016: DURECT Announces First Quarter 2016 Financial Results and Update of Programs
Feb 29, 2016: DURECT Announces Fourth Quarter 2015 Financial Results and Update of Programs
Nov 02, 2015: DURECT Announces Third Quarter 2015 Financial Results and Update of Programs
Aug 03, 2015: DURECT Announces Second Quarter 2015 Financial Results and Update of Programs
Apr 30, 2015: DURECT Announces First Quarter 2015 Financial Results and Update of Programs
Mar 02, 2015: DURECT Announces Fourth Quarter 2014 Financial Results and Update of Programs
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
DURECT Corporation, Key Facts
DURECT Corporation, Key Employees
DURECT Corporation, Key Employee Biographies
DURECT Corporation, Major Products and Services
DURECT Corporation Pipeline Products by Equipment Type
DURECT Corporation Number of Pipeline Products by Development Stage
DURECT Corporation Pipeline Products Summary by Development Stage
DURECT Corporation, History
DURECT Corporation, Key Competitors
DURECT Corporation, Ratios based on current share price
DURECT Corporation, Annual Ratios
DURECT Corporation, Interim Ratios
DURECT Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
DURECT Corporation, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
DURECT Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
DURECT Corporation, Medical Equipment, Deals By Type, 2010 to YTD 2016
DURECT Corporation, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
DURECT Corporation Pipeline Products by Equipment Type
DURECT Corporation Pipeline Products by Development Stage
DURECT Corporation, Performance Chart (2011 - 2015)
DURECT Corporation, Ratio Charts
DURECT Corporation, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
DURECT Corporation, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
DURECT Corporation, Medical Equipment, Deals By Year, 2010 to YTD 2016
DURECT Corporation, Medical Equipment, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report